I migliori medici di Chemioterapia del linfoma - TOP-72medici

Il professor Zafer Gülbaş — ematologo-oncologo, fondatore e direttore del Centro Trapianti di Midollo Osseo dell'Anadolu Medical Center, che è tra i più grandi in Europa.

Perché i pazienti scelgono e si fidano del Dr. Gülbaş:

• Ha creato il Centro Trapianti di Midollo Osseo dell'Anadolu "da zero"; nel centro sono stati eseguiti 3.000+ trapianti (dal 2010).
• 81% di successo nei trapianti autologhi — un alto tasso secondo i dati del centro.
• Formazione internazionale: tirocini e lavoro nei centri leader — Hadassah (Israele), Fred Hutch e MD Anderson (USA), Princess Margaret (Canada).
• 260+ pubblicazioni scientifiche e 5.000+ citazioni — confermano il significativo contributo del professore nella trapiantologia.
• La clinica Anadolu — partner ufficiale di Johns Hopkins Medicine International, che garantisce accesso a protocolli internazionali, consili medici e controllo di qualità.
• Gestisce i casi più complessi: leucemie, linfomi, anemia aplastica, coagulopatie (disturbi della coagulazione).

Il Dott. Solak ha completato una formazione avanzata in oncologia presso l'Istituto Oncologico dell'Università di Hacettepe, uno dei principali centri oncologici della Turchia.

• Specializzato in chemioterapia per vari tipi di cancro, incluso il linfoma
• Formazione specialistica presso il MD Anderson Cancer Center dell'Università del Texas
• Esperienza estesa nel trattamento di tumori della testa e del collo
• Lavora presso l'Hisar Hospital Intercontinental, dotato di strutture moderne

Il medico è un ostetrico e ginecologo altamente esperto con oltre 25 anni nel campo. Specializzandosi in Medicina della Riproduzione in Ostetricia e Ginecologia, il medico è esperto in trattamenti come Inseminazione Intrauterina (IUI), Procedura di Induzione dell'Ovulazione, Perforazione Ovarica e gestione delle Valvole Uretrali.<\/p>

Il medico ha completato una borsa di studio presso il Ronald O Perelman e Claudia Cohen Centre, possiede un diploma dall'Irlanda e ha conseguito un MBBS presso l'Università di Mysore, India.<\/p>

Il medico è il capo del Dipartimento di Oncoematologia e Oncologia Pediatrica presso l'Ospedale Pediatrico Dana Dwek. Specializzandosi in trapianti di midollo osseo e sangue del cordone ombelicale per bambini, il medico ha effettuato oltre 300 trapianti. Con una forte presenza accademica, il medico ha pubblicato 50 articoli e presentato 40 relazioni in varie conferenze mediche. Il medico è membro dell'Associazione Americana di Ematologia e della Società Israeliana di Emato-oncologia Pediatrica, e ha praticato presso il City of Hope Hospital di Los Angeles e in vari centri medici in Israele.<\/p>

Il medico è certificato dal consiglio in Medicina Interna, Ematologia e Oncologia Medica. Il percorso professionale include una residenza presso la State University of New York a Brooklyn e una borsa di studio in Ematologia e Oncologia presso il New York Medical College, Westchester Medical Center.<\/p>

Con un forte impegno nel campo medico, il medico ha pubblicato oltre 30 articoli scientifici e ha contribuito a un capitolo di un libro di testo medico. La competenza è ulteriormente dimostrata dall'esecuzione di diverse centinaia di trapianti di cellule staminali, evidenziando l'esperienza in questo settore.<\/p>

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Omur Gokmen Sevindik is a hematologist at Istanbul Florence Nightingale Hospital. He completed a fellowship at the Mayo Clinic, a top-ranked medical center in the US. Dr. Sevindik specializes in treating blood cancers like leukemia and lymphoma. He works at a JCI-accredited facility that treats 300,000 patients annually.

• Performs allogeneic and haploidentical stem cell transplantations.
• Authored 18 articles in international peer-reviewed journals.
• Presented research findings at over 25 international scientific conferences.
• Treats complex conditions including myeloma, aplastic anemia, and thrombocytopenia.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Experience

• 1990 - 1994 – General Practitioner
• 1994 - 2001 – Research Assistant, Erciyes University, Faculty of Medicine
• 2001 - 2006 – Assistant Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2006 - 2011 – Associate Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2011 - 2019 – Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine

Professional Memberships

• Turkish Society of Hematology
• European Group for Blood and Marrow Transplantation (EBMT)
• Hematologic Oncology Association
• Antalya Medical Chamber

Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.

• Member of the International Society of Pediatric Oncology (SIOP).
• Active member of the European Bone Marrow Transplant Group (EBMT).
• Published more than 40 articles on stem cell therapy and blood disorders.
• Works at a center performing the highest number of transplants in Turkey.

La Professoressa Yeşim Yıldırım — medico oncologo presso l'Anadolu Medical Center (dal 2011). Specialista certificata ESMO, professoressa dal 2021, autrice di oltre 80 pubblicazioni scientifiche. Ha svolto tirocini in prestigiosi centri medici — Rambam (Israele) e Mount Vernon (Regno Unito). Cura il cancro al seno, ai polmoni, del tratto gastrointestinale, il melanoma e i sarcomi, utilizzando terapie immunologiche e mirate.

Perché i pazienti scelgono la dottoressa Yeşim Yıldırım:

• Oltre 20 anni di pratica; professoressa di oncologia medica dal 2021.
• Oltre 80 pubblicazioni recensite sulla biologia dei tumori, terapia immunologica e mirata — i piani di trattamento sono basati su dati aggiornati.
• Certificazione ESMO — principale associazione oncologica europea. Conferma l'alta qualificazione della dottoressa e la formazione continua secondo gli standard mondiali.

Il Prof. Kansoy ha fondato la prima unità di trapianto di midollo osseo pediatrico in Turchia e ha guidato diversi programmi di trapianto a livello nazionale.

• Oltre 30 anni di specializzazione in oncologia e ematologia pediatrica
• Fondatore del Journal of Pediatric Research
• Membro del consiglio delle società di ematologia turche ed europee
• Autore di testi fondamentali sul trapianto di midollo osseo
• Numerosi premi per la ricerca su linfoma e cellule staminali

Prof. Dr. Şebnem İzmir Güner was born in 1970 in Istanbul and took her first steps in her medical career at Istanbul University Faculty of Medicine. Successfully completing her undergraduate and medical education here between 1987-1993, Güner received her internal medicine specialty training at Istanbul University Cerrahpaşa Faculty of Medicine from 1995 to 2000. Deepening her interest in hematology, Prof. Dr. Güner completed her hematology subspecialty training at Cerrahpaşa Faculty of Medicine again between 2003-2006, solidifying her expertise in this field.
Prof. Dr. Güner’s professional journey began as an internal medicine specialist at Istanbul Education and Research Hospital from 2000 to 2003. She established the Hematology Clinic at the same hospital from 2006 to 2010 and served as the responsible physician. Here, she developed innovative approaches in the treatment of patients and made significant contributions to the field of hematology. From 2010 to 2016, she established the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center at Medicalpark Bahçelievler Hospital and served as the responsible physician. During this period, she conducted studies that set national and international standards in the field of hematology.
Between 2016-2018, Prof. Dr. Güner took on similar roles at Şişli Kolon International Hospital, where she was also the founder and responsible physician of the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center. Güner, who became an associate professor in 2017, obtained her professorship title in 2023. Between 2019-2024, she worked at Memorial Şişli Hospital in the Hematology Clinic, Therapeutic Apheresis, and Adult Bone Marrow Transplantation Center.
Prof. Dr. Şebnem İzmir Güner is recognized for her scientific contributions, with over 19 articles published in international peer-reviewed journals. Additionally, she has over 18 articles published in national peer-reviewed journals and 51 presentations at national scientific meetings that have been published in proceedings books. She has also made a name for herself in the academic world with over 18 presentations at meetings and published in proceedings books. Güner, who has held positions on the boards of domestic hematology associations and has active memberships, has crowned her success with more than three awards given at universities and conferences.
Prof. Dr. Şebnem İzmir Güner, who speaks English and German, is also recognized as an educator. In this capacity, she has contributed to the training of young doctors in the field of hematology, providing education to research assistant doctors and students.
Prof. Dr. Şebnem İzmir Güner has established a respected place in the field of hematology with her achievements and scientific contributions throughout her professional life, continuing her career as a physician who inspires her patients and colleagues.

MEDICAL INTERESTS

• Leukemia
• Lymphoma
• Multiple myeloma
• Bone marrow transplantation
• Anemia
• Bleeding and coagulation disorders
• Hemophilia

Dr. Toluy Ozgumus is a hematologist at Hisar Hospital Intercontinental in Istanbul. He has diagnosed and treated over 1,000 patients with bleeding and coagulation disorders. He specializes in the treatment of rare hematological cancers and bone marrow transplantation. Dr. Ozgumus works at a JCI-accredited facility recognized for excellence in hematology-oncology.

• Performs allogenic bone marrow transplants from both related and unrelated donors.
• Treats complex blood cancers including acute leukemia, multiple myeloma, and lymphomas.
• Expert in managing hematological findings related to Covid-19 infections.
• Differentiates myeloproliferative diseases from other causes of blood cell elevation.

Dr. Oguzhan Babacan is a pediatric hematologist-oncologist at Hisar Hospital Intercontinental in Istanbul. He specializes in bone marrow transplantation for children with leukemia and lymphoma. Dr. Babacan has performed allogeneic, autologous, and haploidentical stem cell transplants for 13 years. He treats rare blood disorders and solid tumors in pediatric patients.

• Performs complex bone marrow transplants for leukemia and lymphoma cases.
• Treats childhood blood disorders like thalassemia, hemophilia, and aplastic anemia.
• Expertise in pediatric oncology, including neuroblastoma and Ewing's sarcoma.
• Works at Hisar Hospital, a JCI-accredited facility in Turkey.

Dr. Francesc Cobo Valien is a leading oncohematologist at the Teknon Oncology Institute in Barcelona. He specializes in treating complex blood cancers, including leukemia and lymphoma. Dr. Cobo Valien earned his medical degree and doctorate from the University of Barcelona. He serves patients at Centro Médico Teknon, a JCI-accredited facility.

• Treats acute and chronic leukemia, Hodgkin's lymphoma, and multiple myeloma.
• Performs bone marrow transplants and biological therapy for hematologic malignancies.
• Recipient of the Spanish Hematology Association award for medical reporting.
• Heads research projects supported by the Catalan Society of Hematology.

Il dottore è uno specialista esperto in Trapianto di Midollo Osseo, avendo conseguito la laurea presso la Facoltà di Medicina dell'Università Ebraica nel 1999. Successivamente, il dottore si è specializzato in medicina interna presso il Centro Medico Hadassah. Successivamente, il dottore si è unito al dipartimento di Trapianto di Midollo Osseo presso Hadassah come medico senior, contribuendo con una significativa esperienza nel campo.<\/p>

Il medico è un esperto leader in ematologia e oncologia pediatrica, specializzato in disturbi del sangue e cancro osseo (sarcoma) nei bambini. Attualmente, il medico è direttore del dipartimento di ematologia oncologica pediatrica presso il Sourasky Medical Center di Tel Aviv ed è un pediatra senior presso il Dana Children's Hospital. Il medico coordina il trattamento del cancro osseo e del sarcoma dei tessuti molli, gestisce i disturbi della coagulazione del sangue e supervisiona l'ematologia nei neonati prematuri. Il medico è membro dell'Associazione Israeliana di Emato-Oncologia Pediatrica (ISPHO).

Il medico si è laureato presso l'Università Ben-Gurion e si è specializzato in medicina pediatrica presso il Kaplan Medical Center, con ulteriore specializzazione in ematologia e oncologia pediatrica presso il Schneider Children's Medical Center. Ulteriore formazione è stata completata in oncologia ossea e dei tessuti molli presso l'Istituto Ortopedico Rizzoli in Italia.